In the BioHarmony Drug Report Database

"Preview" Icon

Viltolarsen

Viltepso (viltolarsen) is an oligonucleotide pharmaceutical. Viltolarsen was first approved as Viltepso on 2020-08-12. It is used to treat duchenne muscular dystrophy in the USA. Viltepso’s patent is valid until 2031-08-31 (FDA).

 

Trade Name

 

Viltepso
 

Common Name

 

viltolarsen
 

ChEMBL ID

 

CHEMBL4298062
 

Indication

 

duchenne muscular dystrophy
 

Drug Class

 

Antisense oligonucleotides

Image (chem structure or protein)

Viltolarsen structure rendering